NETs inhibit ferroptosis and CD8 (+) T cell activity through YTHDF2-mediated degradation of SLC2A3 mRNA, demonstrating a mechanism by which NETs alter the tumor microenvironment to support LUAD growth. Here, CD8A is linked to neoplasm.